Padlock Therapeutics Director of Business Development Salaries in Albany, NY
The average Padlock Therapeutics Director of Business Development in Albany, NY earns an estimated $209,279 annually, which includes an estimated base salary of $159,531 with a $49,747 bonus. Padlock Therapeutics' Director of Business Development compensation is $42,976 more than the US average for a Director of Business Development. Director of Business Development salaries at Padlock Therapeutics in Albany, NY can range from $73,000 - $390,000.
In Albany, NY, The Business Development Department at Padlock Therapeutics earns $5,552 more on average than the Marketing Department.
Last updated 5 years ago.
- $159,531
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Padlock Therapeutics
In Albany, NY, Directors of Business Development earn $3,261 more than Directors of Business Development.
Compensation at Padlock Therapeutics by Department
In Albany, NY, The Business Development Department averages $5,552 more than the Marketing Department, and $865 less than the Engineering Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Padlock Therapeutics reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Padlock Therapeutics reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Padlock Therapeutics Rate Their Compensation
The majority of Directors of Business Development at Padlock Therapeutics believe they're compensated fairly. 50% of Directors of Business Development at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics
